Variant report
Variant | esv3527721 |
---|---|
Chromosome Location | chr11:72261655-72264100 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs11821124 | chr11:72261661-72261662 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs559594426 | chr11:72261662-72261663 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs11820623 | chr11:72261664-72261665 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs551544800 | chr11:72261665-72261666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs7104851 | chr11:72261666-72261667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs537082297 | chr11:72261668-72261669 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs548717762 | chr11:72261670-72261671 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs376652331 | chr11:72261673-72261674 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs189745094 | chr11:72261676-72261677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs11821141 | chr11:72261679-72261680 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs115330800 | chr11:72261683-72261684 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs572345645 | chr11:72261709-72261710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs546732436 | chr11:72261710-72261711 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs568475606 | chr11:72261737-72261738 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs529362191 | chr11:72261781-72261782 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs11822802 | chr11:72261785-72261786 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs377377140 | chr11:72261840-72261841 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs550730076 | chr11:72261854-72261855 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs191665877 | chr11:72261957-72261958 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs12365390 | chr11:72261965-72261966 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs573938605 | chr11:72261981-72261982 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs566110183 | chr11:72262054-72262055 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs10793034 | chr11:72262115-72262116 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
24 | rs559581343 | chr11:72262149-72262150 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs533189892 | chr11:72262158-72262159 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs551483553 | chr11:72262175-72262176 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs138020136 | chr11:72262186-72262187 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs530541055 | chr11:72262189-72262190 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs71458284 | chr11:72262207-72262208 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs1695328 | chr11:72262208-72262209 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs529534961 | chr11:72262219-72262220 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs547730368 | chr11:72262292-72262293 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs184344334 | chr11:72262336-72262337 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs539679511 | chr11:72262367-72262368 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs547584102 | chr11:72262379-72262380 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs200816228 | chr11:72262415-72262416 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs142483856 | chr11:72262419-72262420 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs570108030 | chr11:72262429-72262430 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs537155784 | chr11:72262450-72262451 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs555694304 | chr11:72262451-72262452 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs376784438 | chr11:72262466-72262467 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs72958161 | chr11:72262470-72262471 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs188776160 | chr11:72262478-72262479 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs181916055 | chr11:72262484-72262485 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs545160059 | chr11:72262503-72262504 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs143943596 | chr11:72262514-72262515 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs530587437 | chr11:72262526-72262527 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs148615530 | chr11:72262552-72262553 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs187083786 | chr11:72262594-72262595 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs528104071 | chr11:72262599-72262600 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 18632612 | CNVD |
Smith-Lemli-Opitz syndrome | 21572526 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chordoma | 21602918 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 21806811 | CNVD |
Breast cancer | 22002566 | CNVD |
Ductal carcinoma | 18381933 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Breast cancer | 20953835 | CNVD |
oto-dental syndrome | 17656375 | CNVD |
Asthma | 21956041 | CNVD |
Breast cancer | 17603634 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 17001317 | CNVD |
Oral squamous cell carcinoma | 16619035 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Colorectal cancer | 16882699 | CNVD |
Berardinelli-seip congenital generalized lipodystrophy | 17668395 | CNVD |
Spinal muscular atrophy | 17668395 | CNVD |
Neonatal seizures | 17668395 | CNVD |
Neonatal seizures | 17668391 | CNVD |
Neuroticism | 17667963 | CNVD |
Cancer | 17916600 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Multiple endocrine neoplasia type 1 | 19566914 | CNVD |
XY sex reversal | 17503084 | CNVD |
Berardinelli-seip congenital generalized lipodystrophy | 17668391 | CNVD |
Maculopathy | 17646752 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17157792 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Breast cancer | 16620391 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Neuroblastoma | 18923191 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Leukoplakia | 24403051 | CNVD |
Prostate cancer | 17217626 | CNVD |
Cancer | 22429812 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Lung cancer | 19153074 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:72260400-72263200 | Weak transcription | Fetal Muscle Trunk | muscle |
2 | chr11:72260600-72262200 | Weak transcription | Fetal Muscle Leg | muscle |
3 | chr11:72260800-72263400 | Weak transcription | HSMM | muscle |
4 | chr11:72261200-72263200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr11:72261200-72263200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
6 | chr11:72261400-72261800 | Weak transcription | HSMMtube | muscle |
7 | chr11:72261400-72262400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
8 | chr11:72261400-72263400 | Weak transcription | HMEC | breast |
9 | chr11:72261400-72263400 | Weak transcription | NHEK | skin |
10 | chr11:72261800-72262600 | Enhancers | HSMMtube | muscle |
11 | chr11:72262200-72265200 | Enhancers | Fetal Muscle Leg | muscle |
12 | chr11:72262400-72262600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
13 | chr11:72262600-72263000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
14 | chr11:72262600-72263400 | Weak transcription | HSMMtube | muscle |
15 | chr11:72263000-72264200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
16 | chr11:72263200-72263600 | Enhancers | Fetal Muscle Trunk | muscle |
17 | chr11:72263200-72264800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
18 | chr11:72263400-72263600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
19 | chr11:72263400-72264000 | Enhancers | HMEC | breast |
20 | chr11:72263400-72264000 | Enhancers | NHEK | skin |
21 | chr11:72263400-72265400 | Enhancers | HSMM | muscle |
22 | chr11:72263400-72265800 | Enhancers | HSMMtube | muscle |
23 | chr11:72263600-72264000 | Enhancers | Placenta Amnion | Placenta Amnion |
24 | chr11:72263600-72264600 | Weak transcription | Fetal Muscle Trunk | muscle |
25 | chr11:72263800-72264000 | Bivalent Enhancer | IMR90 fetal lung fibroblasts Cell Line | lung |
26 | chr11:72264000-72272600 | Weak transcription | NHEK | skin |